When Bosch says 'don't want to jeopardize the paper by revealing the data too early' that leads me to believe the paper may at least be interesting even if only an update from the prior publication. Imo more important is they tell us of another thing that is in the works and this one should not cost much $ and yet again it disappears and not mentioned again. Not starting all the studies they promised over the years and dissapeared can at least be blamed on no funding, this should have been low cost and could provide interesting data. Just hope they can follow through of the timeline from a week ago and some day in the future tell the story on all the promised over the years and the true reason on the screening halt Think it would be very interesting to hear the results on the group of 25? Confirmed pseudoprogressors excluded from the main trial that have had no mention of for years We will see - I hope
News 
Market Data 
Discover 
